Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas
暂无分享,去创建一个
Kristin R. Swanson | Gargi Chakraborty | Mark Muzi | Alexander M. Spence | Kenneth A. Krohn | Russell Rockne | K. Swanson | R. Rockne | M. Muzi | A. Spence | K. Krohn | H. L. Harpold | Gargi Chakraborty | Christina H. Wang | Hana L.P. Harpold | Tom C.H. Adamsen | T. C. Adamsen | Christina Wang
[1] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] J. Hendry,et al. Radiobiology for the Radiologist , 1979, British Journal of Cancer.
[3] K. Swanson,et al. A mathematical model for glioma growth and invasion links biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET , 2007 .
[4] Jean Charles Gilbert,et al. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] P. J. Green,et al. Probability and Statistical Inference , 1978 .
[6] M. Berridge,et al. An efficient radiosynthesis of [18F]fluoromisonidazole. , 1993, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[7] J. Murray,et al. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy , 2002, British Journal of Cancer.
[8] F. O’Sullivan,et al. Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.
[9] D. Zagzag,et al. Angiogenesis in Gliomas: Biology and Molecular Pathophysiology , 2005, Brain pathology.
[10] Robert C. Rostomily,et al. The cause of death in patients with glioblastoma is multifactorial: , 1991, Journal of Neuro-Oncology.
[11] D. Mankoff,et al. Hypoxia imaging-directed radiation treatment planning , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[12] Thomas K. Lewellen,et al. Investigation of the performance of the General Electric Advance positron emission tomograph in 3D mode , 1995 .
[13] T. Chenevert,et al. The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. , 2006, Cancer research.
[14] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[15] J. Rasey,et al. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. , 1990, Radiation research.
[16] S. Stylli,et al. Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO). , 2002, Nuclear medicine and biology.
[17] F. O’Sullivan,et al. Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival , 2008, Clinical Cancer Research.
[18] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[19] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[20] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] N. van Bruggen,et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media , 1997, Journal of magnetic resonance imaging : JMRI.
[22] M. Slomiany,et al. Hypoxia-Inducible Factor-1-Dependent and -Independent Regulation of Insulin-Like Growth Factor-1-Stimulated Vascular Endothelial Growth Factor Secretion , 2006, Journal of Pharmacology and Experimental Therapeutics.
[23] P. Black,et al. Growth Factors in Glioma Angiogenesis: FGFs, PDGF, EGF, and TGFs , 2000, Journal of Neuro-Oncology.